Literature DB >> 15500295

Retinaldehyde, a potent inhibitor of gap junctional intercellular communication.

Sadhona Pulukuri1, Ari Sitaramayya.   

Abstract

Retinaldehyde and retinoic acid are derivatives of vitamin A, and retinaldehyde is the precursor for the synthesis of retinoic acid, a well-known inhibitor of gap junctional intercellular communication. In this investigation, we asked the question if retinaldehyde has similar effects on gap junctions. Gap junctional intercellular communication was measured by scrape-loading and preloading dye-transfer methods, and studies were carried out mainly on cultured liver epithelial cells. Retinaldehyde was found to be a more potent inhibitor (dye transfer reduced by 50% at 2.8 microM) than retinoic acid (dye transfer reduced by 50% at 30 microM) and glycyrrhetinic acid (dye transfer reduced by 50% at 65 microM). Both the 11-cis and all-trans forms of retinaldehyde were equally effective. Retinaldehyde inhibited dye transfer of both anionic Lucifer yellow and cationic Neurobiotin. Inhibition by retinaldehyde developed in less than two minutes at 50 microM, but unlike the reported case with retinoic acid, recovery was slower, though full. In addition to liver epithelial cells, retinaldehyde inhibited gap junctional communication in lens epithelial cells, retinal pigment epithelial cells and retinal ganglion cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15500295     DOI: 10.1080/15419060490471784

Source DB:  PubMed          Journal:  Cell Commun Adhes        ISSN: 1543-5180


  2 in total

Review 1.  MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy.

Authors:  Bruce A Berkowitz; David Bissig; Oliver Dutczak; Shannon Corbett; Rob North; Robin Roberts
Journal:  Expert Opin Med Diagn       Date:  2013-06-21

2.  Prejunctional and postjunctional actions of heptanol and 18 beta-glycyrretinic acid in the rodent vas deferens.

Authors:  Faisal Rahman; Rohit Manchanda; Keith L Brain
Journal:  Auton Neurosci       Date:  2009-04-16       Impact factor: 3.145

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.